Qiagen NV Company Profile (NASDAQ:QGEN)

About Qiagen NV

Qiagen NV logoQIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Its bioinformatics solutions interpret data to provide actionable insights. Its automation platforms tie these together in molecular testing workflows-from Sample to Insight. Its Sample to Insight molecular technologies are applicable across a range of applications and customer classes through over 500 core consumable products, as well as instruments that automate the use of these products for sample preparation, analysis and interpretation. Its bioinformatics solutions include the Ingenuity, CLC bio, OmicSoft and BIOBASE portfolios. The Company, through OmicSoft Corporation (OmicSoft), offers solution across the data management and interpretation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Research Services
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: QGEN
  • CUSIP: N7248210
Key Metrics:
  • Previous Close: $28.32
  • 50 Day Moving Average: $28.93
  • 200 Day Moving Average: $28.27
  • 52-Week Range: $20.71 - $30.09
  • Trailing P/E Ratio: 80.63
  • Foreward P/E Ratio: 19.96
  • P/E Growth: 1.89
  • Market Cap: $6.36B
  • Outstanding Shares: 225,850,000
  • Beta: 1.05
Profitability:
  • Net Margins: 5.85%
  • Return on Equity: 10.01%
  • Return on Assets: 6.24%
Debt:
  • Debt-to-Equity Ratio: 0.41%
  • Current Ratio: 3.36%
  • Quick Ratio: 2.92%
Additional Links:
Companies Related to Qiagen NV:

Analyst Ratings

Consensus Ratings for Qiagen NV (NASDAQ:QGEN) (?)
Ratings Breakdown: 7 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.42)
Consensus Price Target: $26.33 (6.42% downside)

Analysts' Ratings History for Qiagen NV (NASDAQ:QGEN)
Show:
DateFirmActionRatingPrice TargetDetails
2/6/2017DZ Bank AGReiterated RatingNeutralView Rating Details
2/3/2017Commerzbank AgReiterated RatingBuyView Rating Details
2/3/2017Jefferies Group LLCReiterated RatingNeutral -> HoldView Rating Details
1/30/2017Deutsche Bank AGReiterated RatingBuyView Rating Details
1/9/2017Barclays PLCReiterated RatingBuyView Rating Details
11/3/2016J P Morgan Chase & CoReiterated RatingHold$27.00View Rating Details
11/3/2016Bank of America CorpUpgradeUnderperform -> NeutralView Rating Details
9/11/2016Morgan StanleySet Price TargetBuy$30.00View Rating Details
8/1/2016HSBC Holdings plcUpgradeHold -> BuyView Rating Details
8/1/2016MizuhoBoost Price TargetNeutral$22.00 -> $25.00View Rating Details
7/25/2016Piper Jaffray CompaniesReiterated RatingNeutral$23.00View Rating Details
3/15/2016Citigroup Inc.Lower Price TargetNeutral$28.00 -> $25.00View Rating Details
1/7/2016Cowen and CompanyBoost Price Target$24.00View Rating Details
11/12/2015Stifel NicolausInitiated CoverageHoldView Rating Details
10/30/2015Goldman Sachs Group, Inc. (The)Lower Price Target$22.00 -> $21.00View Rating Details
10/29/2015WedbushLower Price TargetNeutral$21.00 -> $20.00View Rating Details
5/28/2015Credit Suisse GroupReiterated RatingNeutral$24.00 -> $25.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Qiagen NV (NASDAQ:QGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2017        
2/1/2017Q416$0.34$0.39$372.70 million$366.50 millionViewListenView Earnings Details
11/2/2016Q316$0.28$0.29$335.46 million$338.70 millionViewN/AView Earnings Details
7/28/2016Q216$0.23$0.24$326.73 million$334.40 millionViewN/AView Earnings Details
4/27/2016Q116$0.19$0.19$295.76 million$298.40 millionViewN/AView Earnings Details
2/2/2016Q415$0.32$0.33$354.47 million$349.00 millionViewN/AView Earnings Details
10/28/2015Q315$0.28$0.27$323.50 million$314.60 millionViewListenView Earnings Details
7/29/2015Q215$0.25$0.26$319.43 million$319.50 millionViewListenView Earnings Details
5/7/2015Q115$0.22$0.22$304.60 million$298.70 millionViewN/AView Earnings Details
1/28/2015Q414$0.30$0.25$367.82 million$360.80 millionViewN/AView Earnings Details
10/29/2014Q3$0.27$0.27$337.00 million$336.80 millionViewN/AView Earnings Details
7/29/2014Q214$0.25$0.26$330.76 million$331.20 millionViewN/AView Earnings Details
5/7/2014Q114$0.22$0.22$317.09 million$317.40 millionViewN/AView Earnings Details
1/29/2014Q413$0.34$0.36$365.52 million$362.60 millionViewN/AView Earnings Details
10/29/2013Q313$0.25$0.28$320.37 million$323.80 millionViewN/AView Earnings Details
7/30/2013Q213$0.24$0.27$311.75 million$316.40 millionViewN/AView Earnings Details
4/29/2013Q113$0.23$0.23$305.50 million$303.60 millionViewN/AView Earnings Details
1/29/2013Q412$0.31$0.34$327.80 million$346.50 millionViewN/AView Earnings Details
11/5/2012Q312$0.24$0.26$303.79 million$304.30 millionViewN/AView Earnings Details
7/24/2012$0.25$0.25ViewN/AView Earnings Details
4/25/2012$0.21$0.23ViewN/AView Earnings Details
1/31/2012$0.28$0.31ViewN/AView Earnings Details
11/2/2011$0.22$0.24ViewN/AView Earnings Details
7/25/2011$0.23$0.23ViewN/AView Earnings Details
4/27/2011$0.21$0.21ViewN/AView Earnings Details
1/31/2011$0.25$0.26ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Qiagen NV (NASDAQ:QGEN)
Current Year EPS Consensus Estimate: $1.26 EPS
Next Year EPS Consensus Estimate: $1.41 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.19$0.25$0.22
Q2 20164$0.25$0.29$0.27
Q3 20164$0.27$0.30$0.29
Q4 20164$0.33$0.39$0.36
Q1 20171$0.18$0.18$0.18
Q2 20171$0.29$0.29$0.29
Q3 20171$0.32$0.32$0.32
Q4 20171$0.42$0.42$0.42
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Qiagen NV (NASDAQ:QGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Qiagen NV (NASDAQ:QGEN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Qiagen NV (NASDAQ:QGEN)
DateHeadline
News IconAnalysts Peeling Back The Layers on Qiagen NV (NASDAQ:QGEN): Consensus Take - Winfield Review (NASDAQ:QGEN)
winfieldreview.com - February 24 at 12:32 AM
News IconAnalysts Peer Into Their Crystal Balls For Qiagen NV (NASDAQ:QGEN): Where Is It headed? - Winfield Review (NASDAQ:QGEN)
winfieldreview.com - February 22 at 9:29 AM
News IconStock Update: Checking the Technicals for Qiagen NV (QGEN) - Piedmont Register (NASDAQ:QGEN)
piedmontregister.com - February 21 at 5:25 PM
us.rd.yahoo.com logoNew Study Published in Lancet Respiratory Medicine Highlights QIAGEN's QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants (NASDAQ:QGEN)
us.rd.yahoo.com - February 16 at 7:03 PM
us.rd.yahoo.com logoNew Study Published in Lancet Respiratory Medicine Highlights QIAGEN's QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants (NASDAQ:QGEN)
us.rd.yahoo.com - February 16 at 7:03 PM
capitalcube.com logoQIAGEN NV :QGEN-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017 (NASDAQ:QGEN)
www.capitalcube.com - February 8 at 9:49 PM
News IconQIAGEN N.V. Reports Results For Fourth Quarter And Full-Year 2016 (NASDAQ:QGEN)
www.biospace.com - February 6 at 7:32 PM
capitalcube.com logoQIAGEN NV :QGEN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017 (NASDAQ:QGEN)
www.capitalcube.com - February 6 at 7:32 PM
seekingalpha.com logoQIAGEN's (QGEN) CEO Peer Schatz on Q4 2016 Results - Earnings ... - Seeking Alpha (NASDAQ:QGEN)
seekingalpha.com - February 3 at 8:25 PM
fool.com logoQIAGEN NV Continues Its Turnaround (NASDAQ:QGEN)
www.fool.com - February 2 at 10:00 PM
finance.yahoo.com logoEdited Transcript of QGEN earnings conference call or presentation 2-Feb-17 2:00pm GMT (NASDAQ:QGEN)
finance.yahoo.com - February 2 at 10:00 PM
nasdaq.com logoQIAGEN Reaffirms 2017 Outlook - Quick Facts (NASDAQ:QGEN)
www.nasdaq.com - February 1 at 10:23 PM
streetinsider.com logoQiagen (QGEN) Tops Q4 EPS by 5c (NASDAQ:QGEN)
www.streetinsider.com - February 1 at 10:23 PM
biz.yahoo.com logoQ4 2016 Qiagen NV Earnings Release - 4:00 pm ET (NASDAQ:QGEN)
us.rd.yahoo.com - February 1 at 10:23 PM
capitalcube.com logoQIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : February 1, 2017 (NASDAQ:QGEN)
us.rd.yahoo.com - February 1 at 10:23 PM
us.rd.yahoo.com logoQIAGEN Reports Results for Fourth Quarter and Full-year 2016 (NASDAQ:QGEN)
us.rd.yahoo.com - February 1 at 10:23 PM
sg.finance.yahoo.com logoQiagen meets 4Q profit forecasts (NASDAQ:QGEN)
sg.finance.yahoo.com - February 1 at 10:23 PM
us.rd.yahoo.com logoQIAGEN Hereditary and Rare Disease Solution Chosen by Genomics England (NASDAQ:QGEN)
us.rd.yahoo.com - January 31 at 9:25 PM
News IconInvestor Box: Viewing Levels on Shares of Qiagen NV (QGEN) - Springdale Times (NASDAQ:QGEN)
springdaletimes.com - January 30 at 8:06 PM
News IconInvestor Review: Focusing in on Shares of Qiagen NV (QGEN) - Sherwood Daily (NASDAQ:QGEN)
sherwooddaily.com - January 29 at 12:34 AM
us.rd.yahoo.com logoQIAGEN's QuantiFERON-TB Test Wins Tender for Testing of Republic of Korea Armed Forces Recruits (NASDAQ:QGEN)
us.rd.yahoo.com - January 27 at 1:51 AM
finance.yahoo.com logoQIAGEN Announces Adjustment of Conversion Ratio Under its 0.375% Senior Unsecured Convertible Notes due 2019 (ISIN XS1046477235) (NASDAQ:QGEN)
finance.yahoo.com - January 26 at 2:26 AM
News IconStock Perspective: Qiagen N.V. (NASDAQ:QGEN) Company Earnings Watch - Aiken Advocate (NASDAQ:QGEN)
aikenadvocate.com - January 25 at 1:15 AM
realistinvestor.com logoEPS Projection Of Qiagen NV (NASDAQ:QGEN) At $0.4 - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - January 24 at 8:18 AM
News IconAnalysts Pounding The Pavement on Qiagen N.V. (NASDAQ:QGEN): Consensus Update - Wall Street Beacon (NASDAQ:QGEN)
wsbeacon.com - January 24 at 8:18 AM
News IconCrunching the Numbers for Qiagen NV (QGEN) - Springdale Times (NASDAQ:QGEN)
springdaletimes.com - January 23 at 9:16 AM
capitalcube.com logoQIAGEN NV – Value Analysis (NASDAQ:QGEN) : January 19, 2017 (NASDAQ:QGEN)
us.rd.yahoo.com - January 21 at 2:57 AM
News IconWill The Needle Move For Qiagen N.V. (NASDAQ:QGEN) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:QGEN)
wsbeacon.com - January 20 at 6:25 AM
News IconDevling Into Shares of Qiagen N.V. (NASDAQ:QGEN), What Are Analysts Predicting for 2017? - Wall Street Beacon (NASDAQ:QGEN)
wsbeacon.com - January 20 at 6:24 AM
finance.yahoo.com logo4:06 pm Qiagen announces details for completion of a synthetic share repurchase plan that combines a direct capital repayment with a reverse stock split (NASDAQ:QGEN)
finance.yahoo.com - January 19 at 1:03 AM
streetinsider.com logoQiagen (QGEN) Completes $250M Synthetic Share Repurchase (NASDAQ:QGEN)
www.streetinsider.com - January 18 at 8:00 PM
capitalcube.com logoQIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : January 18, 2017 (NASDAQ:QGEN)
us.rd.yahoo.com - January 18 at 8:00 PM
us.rd.yahoo.com logoQIAGEN Announces Details for Completion of Approximately $250 Million Synthetic Share Repurchase (NASDAQ:QGEN)
us.rd.yahoo.com - January 18 at 8:00 PM
finance.yahoo.com logoQIAGEN N.V. to Report Fourth Quarter and Full Year of 2016 Results (NASDAQ:QGEN)
finance.yahoo.com - January 18 at 8:19 AM
realistinvestor.com logoQuarterly Deferred Tax Assets Of Qiagen NV (NASDAQ:QGEN) At $33.068 Millions - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - January 15 at 6:55 PM
seekingalpha.com logoQiagen NV (QGEN) presents at 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:QGEN)
seekingalpha.com - January 12 at 8:04 PM
News IconQIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite - Yahoo Sports (NASDAQ:QGEN)
sports.yahoo.com - January 12 at 1:11 AM
nasdaq.com logoQIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite - Nasdaq (NASDAQ:QGEN)
www.nasdaq.com - January 11 at 8:09 PM
us.rd.yahoo.com logoSingulex Enters into Collaboration with QIAGEN to Develop Companion Diagnostics (NASDAQ:QGEN)
us.rd.yahoo.com - January 10 at 9:00 PM
streetinsider.com logoQiagen (QGEN) Submits QFT-Plus for Regulatory Approval (NASDAQ:QGEN)
www.streetinsider.com - January 10 at 1:08 AM
us.rd.yahoo.com logoQIAGEN Submits QuantiFERON®-TB Gold Plus for U.S. Regulatory Approval (NASDAQ:QGEN)
us.rd.yahoo.com - January 10 at 1:08 AM
us.rd.yahoo.com logo10:01 am Qiagen announces submission of QuantiFERON-TB Gold Plus for pre-market approval by the FDA (NASDAQ:QGEN)
us.rd.yahoo.com - January 10 at 1:08 AM
News IconQiagen N.V. (QGEN) stock slips, "Buy" rating reaffirmed by Barclays PLC Analysts - BNB Daily (blog) (NASDAQ:QGEN)
www.baseball-news-blog.com - January 9 at 8:06 PM
streetinsider.com logoQiagen (QGEN) Submits QFT-Plus for Regulatory Approval - StreetInsider.com (NASDAQ:QGEN)
www.streetinsider.com - January 9 at 8:06 PM
finance.yahoo.com logoQIAGEN Announces Comprehensive Range of Enhancements for GeneReader NGS System (NASDAQ:QGEN)
finance.yahoo.com - January 9 at 8:06 PM
finance.yahoo.com logoQIAGEN Enhances Bioinformatics Portfolio with Acquisition of OmicSoft (NASDAQ:QGEN)
finance.yahoo.com - January 9 at 8:06 PM
realistinvestor.com logoQiagen NV (NASDAQ:QGEN) Is Expected To Post EPS Of $0.3967 - RealistInvestor.com (NASDAQ:QGEN)
www.realistinvestor.com - January 2 at 7:13 PM
stocksdaily.net logoQiagen NV (NASDAQ:QGEN) EPS Projection At $0.35? - Stocks Daily (NASDAQ:QGEN)
www.stocksdaily.net - January 2 at 7:13 PM
zacks.com logoQiagen Poised on Fundamentals, Expansion Plans on Track (NASDAQ:QGEN)
www.zacks.com - December 23 at 8:16 AM
News IconLive stock coverage_ will qiagen nv short squeeze soon_ the stock formed a double top pattern – chester independent future marketing trends 2015 (NASDAQ:QGEN)
getthatmoneyhoney.com - December 17 at 1:17 AM

Social

What is Qiagen NV's stock symbol?

Qiagen NV trades on the NASDAQ under the ticker symbol "QGEN."

Where is Qiagen NV's stock going? Where will Qiagen NV's stock price be in 2017?

12 brokers have issued twelve-month price objectives for Qiagen NV's stock. Their forecasts range from $23.00 to $30.00. On average, they anticipate Qiagen NV's share price to reach $26.33 in the next year.

When will Qiagen NV announce their earnings?

Qiagen NV is scheduled to release their next quarterly earnings announcement on Tuesday, April, 25th 2017.

Who owns Qiagen NV stock?

Qiagen NV's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (3.36%), DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main (1.45%), State Street Corp (1.01%), Credit Agricole S A (0.97%), Frontier Capital Management Co. LLC (0.76%) and Brown Capital Management LLC (0.44%).

Who sold Qiagen NV stock? Who is selling Qiagen NV stock?

Qiagen NV's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Oxford Asset Management, Marshall Wace LLP, Baillie Gifford & Co., Credit Agricole S A, Commerzbank Aktiengesellschaft FI, Guggenheim Capital LLC and State Board of Administration of Florida Retirement System.

Who bought Qiagen NV stock? Who is buying Qiagen NV stock?

Qiagen NV's stock was bought by a variety of institutional investors in the last quarter, including DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Frontier Capital Management Co. LLC, Renaissance Technologies LLC, Russell Investments Group Ltd., Allianz Asset Management AG, State Street Corp, Brown Capital Management LLC and Dimensional Fund Advisors LP.

How do I buy Qiagen NV stock?

Shares of Qiagen NV can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Qiagen NV stock cost?

One share of Qiagen NV stock can currently be purchased for approximately $28.14.

Qiagen NV (NASDAQ:QGEN) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Qiagen NV (NASDAQ:QGEN)

Earnings History Chart

Earnings by Quarter for Qiagen NV (NASDAQ:QGEN)

Dividend History Chart

Dividend Payments by Quarter for Qiagen NV (NASDAQ:QGEN)

Last Updated on 2/25/2017 by MarketBeat.com Staff